INT MEDICAL Reports Annual Profit Increase of 22.43% to 233 Million Yuan

Stock News
03/27

INT MEDICAL (01501) announced its financial results for the year ended December 31, 2025. The company recorded revenue of 1.065 billion yuan, representing a year-on-year increase of 25.06%. Gross profit reached 637 million yuan, up 18.44% compared to the previous year. Net profit amounted to 233 million yuan, a growth of 22.43%. Earnings per share were 1.26 yuan. The board proposed a dividend of 0.23 yuan per share.

According to the announcement, the increase in revenue was driven by a rise in new customers and business consolidation. During the reporting period, revenue from the sales of interventional medical devices was approximately 968 million yuan, an increase of about 25.17% compared to approximately 773 million yuan in the year ended December 31, 2024.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10